CDX2 expression | ||||
---|---|---|---|---|
<5 % | 5–50 % | >50 % | P valuea | |
Frequencies, n (%) | 62 (14.4) | 125 (29.0) | 244 (56.6) | |
MSI screening status, n (%)b | <0.001 | |||
MSI | 27 (41.5) | 14 (21.5) | 24 (36.9) | |
MSS | 33 (9.4) | 108 (30.8) | 210 (59.8) | |
CIMP status, n (%)b | <0.001 | |||
CIMP-negativec | 8 (3.8) | 66 (31.1) | 138 (65.1) | |
CIMP-lowc | 25 (15.6) | 46 (28.8) | 89 (55.6) | |
CIMP-highc | 29 (52.7) | 10 (18.2) | 16 (29.1) | |
BRAF V600E, n (%)b | <0.001 | |||
wild type | 27 (7.4) | 110 (30.3) | 226 (62.3) | |
mutated | 35 (58.3) | 11 (18.3) | 14 (23.3) | |
KRAS (codon 12, 13), n (%)b | 0.027 | |||
wild type | 55 (16.2) | 88 (26.0) | 196 (57.8) | |
mutated | 7 (8.2) | 33 (38.8) | 45 (52.9) | |
SOX2 expression, n (%)b | <0.001 | |||
SOX2 negative | 44 (12.3) | 100 (27.9) | 215 (59.9) | |
SOX2 positive | 15 (32.6) | 19 (41.3) | 12 (26.1) |